Vesugen

Vesugen is a synthetic tripeptide (Lys-Glu-Asp) in the Khavinson family of short peptide bioregulators, associated in the literature with vascular-wall tissue.

It is used as a research tool compound and is studied among the tissue-specific peptide bioregulators in preclinical experimental settings.

It is popularly associated in longevity and biohacking communities with reputed support for vascular and cardiovascular health as a peptide bioregulator.

Vesugen is a short peptide bioregulator that researchers are investigating for its purported effects on the vascular wall, endothelial function, and blood-vessel health — keywords that place it within cardiovascular-longevity discussions.

It is anecdotally reported in biohacking circles to support healthy circulation and age-related vascular resilience, and is popular in longevity communities for these reputed bioregulatory properties.

These are areas of active or preclinical investigation and community interest, not outcomes established in humans.

In cell-culture and animal-model research, investigators have examined Vesugen in relation to vascular tissue, measuring markers of endothelial and vascular-wall cell activity and related gene expression.

These are laboratory observations characterizing measured responses in experimental models, not effects demonstrated in humans.

Vesugen is supplied lyophilized and should be kept at -20°C in a sealed vial, protected from light and moisture prior to use.

For research it is reconstituted with bacteriostatic or sterile water and held at 4°C short-term, or aliquoted and stored at -80°C for longer periods. Each lot includes an HPLC certificate of analysis.